Home > News > Dabur Pharma's Nanoxel receives DCGI approval
February 21st, 2008
Dabur Pharma's Nanoxel receives DCGI approval
Abstract:
Dabur Pharma announced that the Drug Controller General of India (DCGI) has approved its proprietary nanoparticle Paclitaxel formulation ‘Nanoxel' for additional indications of ovarian cancer, non-small cell lung cancer and AIDS related Kaposis's sarcoma. Speaking on the occasion Ajay Kumar Vij, CEO, Dabur Pharma said, "We are very pleased by DCGI's decision. Consistent with our mission of making cancer therapy available to more people, this approval will help a much larger patient population have access to a significantly safer and more convenient therapeutic alternative to conventional Paclitaxel." Nanoxel is a cremophor free polymeric nanoparticle formulation of Paclitaxel with no hypersensitivity reactions, which allows administration to patients without cumbersome pre-medication as is required with cremophor Paclitaxel.
Source:
expresspharmaonline.com
Bookmark:
| Related News Press |
News and information
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Govt.-Legislation/Regulation/Funding/Policy
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Institute for Nanoscience hosts annual proposal planning meeting May 16th, 2025
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||